Literature DB >> 17379019

Soluble tumor necrosis factor receptor 2 is independently associated with pulse wave velocity in nonobese Japanese patients with type 2 diabetes mellitus.

Minako Ohgushi1, Ataru Taniguchi, Mitsuo Fukushima, Yoshikatsu Nakai, Akira Kuroe, Michihiro Ohya, Shoichiro Nagasaka, Yoshiro Taki, Satoru Yoshii, Kazunari Matsumoto, Yuichiro Yamada, Nobuya Inagaki, Yutaka Seino.   

Abstract

The aim of the present study was to investigate the factors contributing to pulse wave velocity (PWV) in patients with type 2 diabetes mellitus. We focused on tumor necrosis factor (TNF) including soluble TNF receptors (sTNF-R1, sTNF-R2) in this study because TNF seems to be associated with the progression of atherosclerosis and because the relationships between PWV and TNF were not yet examined in type 2 diabetic patients. Univariate regression analyses showed that PWV was positively correlated with age (r=0.492, P<.001), diabetes duration (r=0.251, P=.021), systolic (r=.595, P<.001) and diastolic (r=0.248, P=.022) blood pressure, antihypertensive medication (r=0.268, P=.013), and the concentrations of sTNF-R1 (r=0.354, P=.001) and sTNF-R2 (r=0.415, P<.001). Although there was a positive correlation between TNF-alpha and sTNF-R1 (r=0.382, P<.001) or sTNF-R2 (r=0.394, P<.001), TNF-alpha was not associated with PWV. Other variables including gender were not associated with PWV. Multiple regression analyses showed that PWV was independently predicted by the level of age (F=15.1), systolic blood pressure (F=31.6), and sTNF-R2 (F=5.2), which explained 49.2% of the variability of PWV. From these results, it can be concluded that serum soluble TNF receptor is an important independent factor associated with aortic PWV in type 2 diabetic patients.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17379019     DOI: 10.1016/j.metabol.2006.12.007

Source DB:  PubMed          Journal:  Metabolism        ISSN: 0026-0495            Impact factor:   8.694


  6 in total

1.  Inflammatory markers are associated with risk of colorectal cancer and chemopreventive response to anti-inflammatory drugs.

Authors:  Andrew T Chan; Shuji Ogino; Edward L Giovannucci; Charles S Fuchs
Journal:  Gastroenterology       Date:  2010-11-27       Impact factor: 22.682

2.  Soluble TNF and IL-6 receptors: indicators of vascular health in women without cardiovascular disease.

Authors:  Miriam Cortez-Cooper; Eric Meaders; Judith Stallings; Sara Haddow; Barbara Kraj; Gloria Sloan; Kevin K McCully; Joseph G Cannon
Journal:  Vasc Med       Date:  2013-10       Impact factor: 3.239

3.  Smoking, white blood cell counts, and TNF system activity in Japanese male subjects with normal glucose tolerance.

Authors:  Naoya Watanabe; Mitsuo Fukushima; Ataru Taniguchi; Takahide Okumura; Yoshio Nomura; Fusanori Nishimura; Sae Aoyama; Daisuke Yabe; Yoshio Izumi; Ryoichi Ohtsubo; Yoshikatsu Nakai; Shoichiro Nagasaka
Journal:  Tob Induc Dis       Date:  2011-11-25       Impact factor: 2.600

4.  Association of soluble tumor necrosis factor receptors 1 and 2 with nephropathy, cardiovascular events, and total mortality in type 2 diabetes.

Authors:  Axel C Carlsson; Carl Johan Östgren; Fredrik H Nystrom; Toste Länne; Pär Jennersjö; Anders Larsson; Johan Ärnlöv
Journal:  Cardiovasc Diabetol       Date:  2016-02-29       Impact factor: 9.951

5.  Identification of novel biomarkers to monitor β-cell function and enable early detection of type 2 diabetes risk.

Authors:  Kirstine J Belongie; Ele Ferrannini; Kjell Johnson; Patricia Andrade-Gordon; Michael K Hansen; John R Petrie
Journal:  PLoS One       Date:  2017-08-28       Impact factor: 3.240

6.  10-Year Associations Between Tumor Necrosis Factor Receptors 1 and 2 and Cardiovascular Events in Patients With Stable Coronary Heart Disease: A CLARICOR (Effect of Clarithromycin on Mortality and Morbidity in Patients With Ischemic Heart Disease) Trial Substudy.

Authors:  Axel C Carlsson; Toralph Ruge; Erik Kjøller; Jørgen Hilden; Hans Jørn Kolmos; Ahmad Sajadieh; Jens Kastrup; Gorm Boje Jensen; Anders Larsson; Christoph Nowak; Janus Christian Jakobsen; Per Winkel; Christian Gluud; Johan Ärnlöv
Journal:  J Am Heart Assoc       Date:  2018-04-23       Impact factor: 5.501

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.